Concepedia

J. Michael Bradshaw

JM

Statistics

Publications

30

Citations

2.3K

H-Index

25

Active since

1998

Affiliations

Principia Biopharma (United States)(Current)

Washington University in St. Louis

Roche (United States)

Stanford University

Roche (Switzerland)

J. Michael Bradshaw is an author at Principia Biopharma (United States) specializing in life sciences, biochemistry, and signal transduction.

Publications per year

1998–2022

30

Publications

30

Prolonged and tunable residence time using reversible covalent kinase inhibitors

J. Michael Bradshaw, Jesse M. McFarland, Ville O. Paavilainen et al. · Nature Chemical Biology · 2015 · 430 citations · Full text

, , +14

An ultrasensitive Ca <sup>2+</sup> /calmodulin-dependent protein kinase II-protein phosphatase 1 switch facilitates specificity in postsynaptic calcium signaling

J. Michael Bradshaw, Yoshi Kubota, Tobias Meyer et al. · Proceedings of the National Academy of Sciences · 2003 · 198 citations · Full text

, , +17

Molecular Mechanism of the Syk Activation Switch

Emily K. Tsang, Anthony M. Giannetti, David E. Shaw et al. · Journal of Biological Chemistry · 2008 · 161 citations · Full text

, , +15

Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase 1 1Edited by P. E. Wright

J. Michael Bradshaw, Vesselin Mitaxov, Gabriel Waksman · Journal of Molecular Biology · 1999 · 146 citations

, , +14

Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease

Claire L. Langrish, J. Michael Bradshaw, Michelle Francesco et al. · The Journal of Immunology · 2021 · 124 citations · Full text

, , +17

1–5 of 30